Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guislaine Carcelain

Showing results (51-60 of 77) with videos related to

Pageof 8
Sort By:
AIDS (London, England)|January 10, 2014
Differential impact of APOBEC3-driven mutagenesis on HIV evolution in diverse anatomical compartmentsSlim Fourati, Sidonie Lambert-Niclot, Cathia Soulie, et al.
AIDS (London, England)|December 3, 2009
Immune and virological benefits of 10 years of permanent viral control with antiretroviral therapyAmélie Guihot, Roland Tubiana, Guillaume Breton, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 14, 2006
HIV-specific antibodies but not t-cell responses are associated with protection in seronegative partners of HIV-1-infected individuals in CambodiaMarie Nguyen, Polidy Pean, Lucia Lopalco, et al.
The Journal of Infectious Diseases|April 22, 2017
Identifying Cytomegalovirus Complications Using the Quantiferon-CMV Assay After Allogeneic Hematopoietic Stem Cell TransplantationMichelle K Yong, Paul U Cameron, Monica Slavin, et al.
The Journal of Antimicrobial Chemotherapy|June 13, 2012
HIV-1 genome is often defective in PBMCs and rectal tissues after long-term HAART as a result of APOBEC3 editing and correlates with the size of reservoirsSlim Fourati, Sidonie Lambert-Niclot, Cathia Soulie, et al.
Vaccine|June 2, 2005
Therapeutic immunization with a human immunodeficiency virus (HIV) type 1-recombinant canarypox vaccine in chronically HIV-infected patients: The Vacciter Study (ANRS 094)Roland Tubiana, Guislaine Carcelain, Muriel Vray, et al.
Blood|January 7, 2017
iNKT and memory B-cell alterations in HHV-8 multicentric Castleman diseaseZineb Sbihi, Antoine Dossier, David Boutboul, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 25, 2016
Determinants of a Low CD4/CD8 Ratio in HIV-1-Infected Individuals Despite Long-term Viral SuppressionFabienne Caby, Amélie Guihot, Sidonie Lambert-Niclot, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 26, 2013
Recalcitrant pseudotumoral anogenital herpes simplex virus type 2 in HIV-infected patients: evidence for predominant B-lymphoplasmocytic infiltration and immunomodulators as effective therapeutic strategyEmilie Sbidian, Maxime Battistella, Jérome Legoff, et al.
The Journal of Antimicrobial Chemotherapy|November 5, 2013
Factors associated with a low HIV reservoir in patients with prolonged suppressive antiretroviral therapySlim Fourati, Philippe Flandre, Ruxandra Calin, et al.
Pageof 8

Showing results (51-60 of 77) with videos related to

Sort By:
Pageof 8
AIDS (London, England)|January 10, 2014
Differential impact of APOBEC3-driven mutagenesis on HIV evolution in diverse anatomical compartmentsSlim Fourati, Sidonie Lambert-Niclot, Cathia Soulie, et al.
AIDS (London, England)|December 3, 2009
Immune and virological benefits of 10 years of permanent viral control with antiretroviral therapyAmélie Guihot, Roland Tubiana, Guillaume Breton, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 14, 2006
HIV-specific antibodies but not t-cell responses are associated with protection in seronegative partners of HIV-1-infected individuals in CambodiaMarie Nguyen, Polidy Pean, Lucia Lopalco, et al.
The Journal of Infectious Diseases|April 22, 2017
Identifying Cytomegalovirus Complications Using the Quantiferon-CMV Assay After Allogeneic Hematopoietic Stem Cell TransplantationMichelle K Yong, Paul U Cameron, Monica Slavin, et al.
The Journal of Antimicrobial Chemotherapy|June 13, 2012
HIV-1 genome is often defective in PBMCs and rectal tissues after long-term HAART as a result of APOBEC3 editing and correlates with the size of reservoirsSlim Fourati, Sidonie Lambert-Niclot, Cathia Soulie, et al.
Vaccine|June 2, 2005
Therapeutic immunization with a human immunodeficiency virus (HIV) type 1-recombinant canarypox vaccine in chronically HIV-infected patients: The Vacciter Study (ANRS 094)Roland Tubiana, Guislaine Carcelain, Muriel Vray, et al.
Blood|January 7, 2017
iNKT and memory B-cell alterations in HHV-8 multicentric Castleman diseaseZineb Sbihi, Antoine Dossier, David Boutboul, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 25, 2016
Determinants of a Low CD4/CD8 Ratio in HIV-1-Infected Individuals Despite Long-term Viral SuppressionFabienne Caby, Amélie Guihot, Sidonie Lambert-Niclot, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 26, 2013
Recalcitrant pseudotumoral anogenital herpes simplex virus type 2 in HIV-infected patients: evidence for predominant B-lymphoplasmocytic infiltration and immunomodulators as effective therapeutic strategyEmilie Sbidian, Maxime Battistella, Jérome Legoff, et al.
The Journal of Antimicrobial Chemotherapy|November 5, 2013
Factors associated with a low HIV reservoir in patients with prolonged suppressive antiretroviral therapySlim Fourati, Philippe Flandre, Ruxandra Calin, et al.
Pageof 8